Caas Capital Management LP 10x Genomics, Inc. Transaction History

Caas Capital Management LP

  • $836 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021
SELL
$126.47 - $163.7 $63.2 Million - $81.8 Million
-499,456 Closed
0 $0
Q3 2020

Nov 09, 2020
SELL
$87.44 - $125.0 $4.24 Million - $6.06 Million
-48,460 Reduced 8.84%
499,456 $62.3 Million
Q2 2020

Aug 14, 2020
BUY
$58.39 - $89.31 $32 Million - $48.9 Million
547,916 New
547,916 $48.9 Million

Others Institutions Holding TXG

# of Institutions
287
Shares Held
94.9M
Call Options Held
162K
Put Options Held
107K
View Full List

About 10x Genomics, Inc.

TXG Quotes by TradingView
  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.54B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Caas Capital Management LP Portfolio

Follow Caas Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Caas Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email